Search results for "Gastroenterology"
Obituaries
The College notes the passing of James (Jim) Foody III, MD, FACP; Marcus Boyd Shook, MD, MACP; C. Anderson (Andy) Hedberg, MD, MACP; and George Goldsand, MD, MACP.
https://immattersacp.org/archives/2023/02/obits.htm
1 Feb 2023
Improving celiac disease diagnosis
Celiac disease should be part of the differential diagnosis for several classic clinical presentations, but atypical symptoms, including constipation, can cause doctors to overlook some patients.
https://immattersacp.org/archives/2023/02/improving-celiac-disease-diagnosis.htm
1 Feb 2023
ACG updates, reaffirms guidelines on evaluation, management of patients with celiac disease
The diagnostic approach to celiac disease in adults using serological and histologic data remains unchanged from the American College of Gastroenterology's (ACG) 2013 clinical guidelines.
https://immattersacp.org/weekly/archives/2023/01/17/1.htm
17 Jan 2023
More tools available for treating IBS
Irritable bowel syndrome (IBS) is not a new disorder, but physicians' understanding of its pathophysiology and treatment has greatly progressed over the years.
https://immattersacp.org/archives/2023/01/more-tools-available-for-treating-ibs.htm
1 Jan 2023
New guidance, treatments for IBS
This month's issue addresses irritable bowel syndrome (IBS), bereavement among patients, and transgender care.
https://immattersacp.org/archives/2023/01/new-guidance-treatments-for-ibs.htm
1 Jan 2023
MKSAP Quiz: Follow-up after severe acute pancreatitis and abdominal pain
This week's quiz asks readers to choose the most appropriate management of a 55-year-old man who was hospitalized two months ago for severe acute pancreatitis and had hypodense pancreatic lesions two weeks ago on contrast-enhanced pancreas-protocol CT.
https://immattersacp.org/weekly/archives/2022/11/29/3.htm
29 Nov 2022
Response to linaclotide for IBS constipation can still appear after four weeks
An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.
https://immattersacp.org/weekly/archives/2022/11/22/4.htm
22 Nov 2022
Guideline suggests prescription medications when lifestyle change ineffective for weight loss
For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://immattersacp.org/weekly/archives/2022/10/25/1.htm
25 Oct 2022
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://immattersacp.org/weekly/archives/2022/09/27/1.htm
27 Sep 2022
MKSAP Quiz: Evaluation for recurrent diarrhea, abdominal pain
A 57-year-old man is evaluated for recurrent diarrhea and abdominal pain over the past 2 months. He was diagnosed with celiac disease 10 years ago when he presented with similar symptoms; at that time, symptoms resolved within 1 month of starting a gluten-free diet, which he has maintained since then. He has unintentionally lost 2 kg (5 lb) in the past 2 months. What condition should he be assessed for?
https://immattersacp.org/weekly/archives/2022/09/06/3.htm
6 Sep 2022